Pael-R (GPR37) Antibody (C-term) Blocking Peptide

Pael-R (GPR37) Antibody (C-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP6410b
Catalog Number: AC-BP6410b
Size: 500 µg
Datasheet
Request Information
Background:
Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson disease identified to date. The function of Park2 is not well-known; however, it may play a role in the ubiquitin-mediated proteolytic pathway. Mutations in this gene are known to cause autosomal recessive juvenile parkinsonism. Alternative splicing of this gene produces three known products of undetermined function. Panneuronal expression of Parkin substrate Pael-R causes age-dependent selective degeneration of Drosophila dopaminergic (DA) neurons; coexpression of Parkin degrades Pael-R and suppresses its toxicity.

Other Names:
Prosaposin receptor GPR37, Endothelin B receptor-like protein 1, ETBR-LP-1, G-protein coupled receptor 37, Parkin-associated endothelin receptor-like receptor, PAELR, GPR37

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6410b was selected from the GPR37 region of human Pael-R (GPR37). A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: GPR37

Gene ID: 2861
Primary Accession: O15354
Other Accession: NP_005293
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:Pael-R (GPR37) Antibody (C-term) Blocking Peptide